{"DataElement":{"publicId":"3219607","version":"1","preferredName":"Protocol Therapeutic Procedure Discontinue Administration Reason","preferredDefinition":"the reason protocol therapy was discontinued.","longName":"3219602v1.0:3219603v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3219602","version":"1","preferredName":"Protocol Therapeutic Procedure Discontinue Administration","preferredDefinition":"information related to the discontinuation of an action or administration of protocol-defined therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"3219608v1.0:2207230v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3219608","version":"1","preferredName":"Protocol Therapeutic Procedure","preferredDefinition":"A protocol is a rule which guides how an activity should be performed; a set of formal rules used to specify the format of an exchange of data.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C42651:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-3036-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207230","version":"1","preferredName":"Discontinued Administration","preferredDefinition":"Discontinued; stopped permanently or temporarily.:The act of administration.","longName":"C25484:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1D15-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-2E50-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3219603","version":"1","preferredName":"Protocol Therapy Discontinue Reason","preferredDefinition":"The reason protocol therapy was discontinued.","longName":"3219603v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Failure to submit tissue assay","valueDescription":"Failure to submit tissue assay","ValueMeaning":{"publicId":"3219604","version":"1","preferredName":"Failure to submit tissue assay","longName":"3219604","preferredDefinition":"Failure to submit tissue assay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-2E76-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A018F73A-2E8F-0240-E040-BB89AD43705F","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","deletedIndicator":"No"},{"value":"Physician preference","valueDescription":"Physician Preference","ValueMeaning":{"publicId":"2705082","version":"1","preferredName":"Physician Preference","longName":"2705082","preferredDefinition":"Physician Preference","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4063572B-79CA-211D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A018F73A-2E99-0240-E040-BB89AD43705F","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","deletedIndicator":"No"},{"value":"Patient refusal","valueDescription":"Patient refusal","ValueMeaning":{"publicId":"3219605","version":"1","preferredName":"Patient refusal","longName":"3219605","preferredDefinition":"Patient refusal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-2EA3-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A018F73A-2EBC-0240-E040-BB89AD43705F","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","deletedIndicator":"No"},{"value":"Progression of disease","valueDescription":"progression of disease","ValueMeaning":{"publicId":"3219606","version":"1","preferredName":"progression of disease","longName":"3219606","preferredDefinition":"progression of disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-2EC6-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A018F73A-2EDF-0240-E040-BB89AD43705F","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A018F73A-2EE9-0240-E040-BB89AD43705F","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"ONEDATA","dateModified":"2011-04-04","deletedIndicator":"No"},{"value":"Patient is p16 positive","valueDescription":"Patient is p16 positive","ValueMeaning":{"publicId":"3595826","version":"1","preferredName":"Patient is p16 positive","longName":"3595826","preferredDefinition":"Patient is p16 positive shown by central p16 analysis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA7887F9-EF1D-8326-E040-BB89AD4376CE","latestVersionIndicator":"Yes","beginDate":"2012-09-24","endDate":null,"createdBy":"PATELV","dateCreated":"2012-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CA7887F9-EF36-8326-E040-BB89AD4376CE","beginDate":"2012-09-24","endDate":null,"createdBy":"PATELV","dateCreated":"2012-09-24","modifiedBy":"ONEDATA","dateModified":"2012-09-24","deletedIndicator":"No"},{"value":"Patient is p16 not evaluable","valueDescription":"Patient is p16 not evaluable","ValueMeaning":{"publicId":"3623898","version":"1","preferredName":"Patient is p16 not evaluable","longName":"3623898","preferredDefinition":"Patient is p16 not evaluable shown by central p16 analysis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCF6C03A-2435-D922-E040-BB89AD4320FA","latestVersionIndicator":"Yes","beginDate":"2012-10-26","endDate":null,"createdBy":"PATELV","dateCreated":"2012-10-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCF6C03A-244E-D922-E040-BB89AD4320FA","beginDate":"2012-10-26","endDate":null,"createdBy":"PATELV","dateCreated":"2012-10-26","modifiedBy":"ONEDATA","dateModified":"2012-10-26","deletedIndicator":"No"},{"value":"5th cycle not started(Gem +/- Erlotinib)","valueDescription":"5th cycle not started(Gem +/- Erlotinib)","ValueMeaning":{"publicId":"3775512","version":"1","preferredName":"5th cycle not started(Gem +/- Erlotinib)","longName":"3775512","preferredDefinition":"5th cycle not started(Gem +/- Erlotinib)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE7C4E7B-BB3E-167C-E040-BB89AD432E95","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE7C4E7B-BB57-167C-E040-BB89AD432E95","beginDate":"2013-06-06","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"Other specify","valueDescription":"Other specify","ValueMeaning":{"publicId":"3772693","version":"1","preferredName":"Other specify","longName":"3772693","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDE11263-D603-3345-E040-BB89AD432069","latestVersionIndicator":"Yes","beginDate":"2013-05-29","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE7C4E7B-BB6B-167C-E040-BB89AD432E95","beginDate":"2013-06-06","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"failure to submit completed EPIC form","valueDescription":"Failure To Submission Complete Expanded Prostate Cancer Index Composite Form","ValueMeaning":{"publicId":"3912534","version":"1","preferredName":"Failure To Submission Complete Expanded Prostate Cancer Index Composite Form","longName":"3912534","preferredDefinition":"A lack of occurrence or performance.: Used as a function word to indicate direction, purpose, or movement.: The act of referring for judgment or consideration by others; the act of handing over something.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: A self-administered questionnaire designed to evaluate patient function and bother after prostate cancer treatment.: A printed or electronic document with spaces to be filled out.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Submission","conceptCode":"C25695","definition":"The act of referring for judgment or consideration by others; the act of handing over something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Expanded Prostate Cancer Index Composite","conceptCode":"C107630","definition":"A self-administered questionnaire designed to evaluate patient function and bother after prostate cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Form","conceptCode":"C19464","definition":"A printed or electronic document with spaces to be filled out.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B1BA21-6746-C7D5-E040-BB89AD43769F","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"WELSHE","dateCreated":"2013-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7B1BA21-675F-C7D5-E040-BB89AD43769F","beginDate":"2013-10-01","endDate":null,"createdBy":"WELSHE","dateCreated":"2013-10-01","modifiedBy":"ONEDATA","dateModified":"2013-10-01","deletedIndicator":"No"},{"value":"failure to complete 12 or more bowel items on the EPIC form","valueDescription":"Failure To Complete Number Or Additional Bowel Description Contain Expanded Prostate Cancer Index Composite Form","ValueMeaning":{"publicId":"3912543","version":"1","preferredName":"Failure To Complete Number Or Additional Bowel Description Contain Expanded Prostate Cancer Index Composite Form","longName":"3912543","preferredDefinition":"A lack of occurrence or performance.: Used as a function word to indicate direction, purpose, or movement.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.: Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Added; extra; further.: (in-TES-tin) The long, tube-shaped organ in the abdomen that completes the process of digestion. There is both a large intestine and a small intestine. Also called the bowel.: A written or verbal account, representation, statement, or explanation of something.: Include or hold; have within or as a component.: A self-administered questionnaire designed to evaluate patient function and bother after prostate cancer treatment.: A printed or electronic document with spaces to be filled out.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"10"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"9"},{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Intestine","conceptCode":"C12736","definition":"The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Contain","conceptCode":"C79873","definition":"Include or hold; have within or as a component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Expanded Prostate Cancer Index Composite","conceptCode":"C107630","definition":"A self-administered questionnaire designed to evaluate patient function and bother after prostate cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Form","conceptCode":"C19464","definition":"A printed or electronic document with spaces to be filled out.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7B18233-A9A1-8946-E040-BB89AD433CF4","latestVersionIndicator":"Yes","beginDate":"2013-10-01","endDate":null,"createdBy":"WELSHE","dateCreated":"2013-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7B18233-A9BA-8946-E040-BB89AD433CF4","beginDate":"2013-10-01","endDate":null,"createdBy":"WELSHE","dateCreated":"2013-10-01","modifiedBy":"ONEDATA","dateModified":"2013-10-01","deletedIndicator":"No"},{"value":"Patient is not p16 positive","valueDescription":"Patient Negation Human Papillomavirus-16 Positive","ValueMeaning":{"publicId":"3918192","version":"1","preferredName":"Patient Negation Human Papillomavirus-16 Positive","longName":"3918192","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: An operation in which a term denies or inverts the meaning of another term or construction.: A strain of the human papillomavirus virus, (HPV16), has been directly linked to cervical cancer and is significantly associated with invasiveness. The papillomavirus virus constitutes a protein coat (capsid) surrounding a circular, double-stranded DNA organised into coding and non-coding regions, and induces skin and mucosal epithelial lesions. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 virus genome into the host chromosome. The event occurs with disruption or deletion of the E2 ORF followed by inactivation of the E2 regulatory protein.: Involving advantage or good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Papillomavirus-16","conceptCode":"C14338","definition":"A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-16 (HPV16) has been directly linked to cervical cancer and is significantly associated with invasiveness. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 genome into the host chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E86504E3-C354-081D-E040-BB89AD432852","latestVersionIndicator":"Yes","beginDate":"2013-10-10","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E86504E3-C36D-081D-E040-BB89AD432852","beginDate":"2013-10-10","endDate":null,"createdBy":"PATELV","dateCreated":"2013-10-10","modifiedBy":"ONEDATA","dateModified":"2013-10-10","deletedIndicator":"No"},{"value":"Undetectable plasma EBV DNA","valueDescription":"Absent Plasma Epstein-Barr Virus DNA","ValueMeaning":{"publicId":"3876185","version":"1","preferredName":"Absent Plasma Epstein-Barr Virus DNA","longName":"3876185","preferredDefinition":"Not existing in a specified place at a specified time.: Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.: A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.: A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Plasma","conceptCode":"C13356","definition":"Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A8347A-7EC8-747B-E040-BB89AD4312D0","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5A8347A-7EE3-747B-E040-BB89AD4312D0","beginDate":"2013-09-05","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","deletedIndicator":"No"},{"value":"failure to submit plasma for analysis","valueDescription":"Failure To Submission Plasma Analysis","ValueMeaning":{"publicId":"3876186","version":"1","preferredName":"Failure To Submission Plasma Analysis","longName":"3876186","preferredDefinition":"A lack of occurrence or performance.: Used as a function word to indicate direction, purpose, or movement.: The act of referring for judgment or consideration by others; the act of handing over something.: Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.: Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Submission","conceptCode":"C25695","definition":"The act of referring for judgment or consideration by others; the act of handing over something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Plasma","conceptCode":"C13356","definition":"Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Analysis","conceptCode":"C25391","definition":"Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A8347A-7EF3-747B-E040-BB89AD4312D0","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5A8347A-7F0E-747B-E040-BB89AD4312D0","beginDate":"2013-09-05","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","deletedIndicator":"No"},{"value":"Death","valueDescription":"Death","ValueMeaning":{"publicId":"3141242","version":"1","preferredName":"Death","longName":"3141242","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90DEC4CC-5E17-3212-E040-BB89AD436EBB","latestVersionIndicator":"Yes","beginDate":"2010-09-22","endDate":null,"createdBy":"LUY","dateCreated":"2010-09-22","modifiedBy":"GDEEN","dateModified":"2023-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F442BE29-C8C6-432C-E040-BB89AD4375DE","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","deletedIndicator":"No"},{"value":"Toxicity","valueDescription":"Toxicity","ValueMeaning":{"publicId":"2560295","version":"1","preferredName":"Toxicity","longName":"2560295","preferredDefinition":"Toxicity; the degree to which something is poisonous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B894-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2012-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F442BE29-C8D0-432C-E040-BB89AD4375DE","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","deletedIndicator":"No"},{"value":"Other complicating disease","valueDescription":"Other Complicating Disease or Disorder","ValueMeaning":{"publicId":"4204874","version":"1","preferredName":"Other Complicating Disease or Disorder","longName":"4204874","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Making more complex or intricate.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Complicating","conceptCode":"C25455","definition":"Making more complex or intricate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F442BE29-C8DE-432C-E040-BB89AD4375DE","latestVersionIndicator":"Yes","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F442BE29-C8F7-432C-E040-BB89AD4375DE","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","deletedIndicator":"No"},{"value":"InsufficientTissue","valueDescription":"Inadequate tissue","ValueMeaning":{"publicId":"2734581","version":"1","preferredName":"Inadequate tissue","longName":"2734581","preferredDefinition":"Inadequate tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"483D77AB-6309-22B2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-03-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F442BE29-C90B-432C-E040-BB89AD4375DE","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","deletedIndicator":"No"},{"value":"Checklist failure, specify","valueDescription":"Specify Checklist Failure","ValueMeaning":{"publicId":"4204875","version":"1","preferredName":"Specify Checklist Failure","longName":"4204875","preferredDefinition":"Be specific about something; define clearly.: A list of items required or things to be done or considered.: A lack of occurrence or performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Checklist","conceptCode":"C49073","definition":"A list of items required or things to be done or considered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F442BE29-C91A-432C-E040-BB89AD4375DE","latestVersionIndicator":"Yes","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F442BE29-C933-432C-E040-BB89AD4375DE","beginDate":"2014-03-10","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-10","modifiedBy":"ONEDATA","dateModified":"2014-03-10","deletedIndicator":"No"},{"value":"Neurocognitive assessment not completed","valueDescription":"Neurocognitive Assessment Negation Complete","ValueMeaning":{"publicId":"4541491","version":"1","preferredName":"Neurocognitive Assessment Negation Complete","longName":"4541491","preferredDefinition":"Having to do with the ability to think and reason. This includes the ability to concentrate, remember things, process information, learn, speak, and understand.: The final result of a determination of the value, significance, or extent of.: An operation in which a term denies or inverts the meaning of another term or construction.: To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurocognitive","conceptCode":"C94321","definition":"Having to do with the ability to think and reason. This includes the ability to concentrate, remember things, process information, learn, speak, and understand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete","conceptCode":"C25250","definition":"To possess every necessary or normal part or component or step; having come or been brought to a conclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DB53A2-2DC3-E4B3-E050-BB89AD430E4B","latestVersionIndicator":"Yes","beginDate":"2014-10-20","endDate":null,"createdBy":"PATELV","dateCreated":"2014-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05DB53A2-2DDC-E4B3-E050-BB89AD430E4B","beginDate":"2014-10-20","endDate":null,"createdBy":"PATELV","dateCreated":"2014-10-20","modifiedBy":"ONEDATA","dateModified":"2014-10-20","deletedIndicator":"No"},{"value":"5th month of treatment not started","valueDescription":"Fifth month of treatment not started","ValueMeaning":{"publicId":"5292875","version":"1","preferredName":"Fifth month of treatment not started","longName":"5292875","preferredDefinition":"Fifth month of treatment not started","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3542E427-B23D-8E24-E050-BB89AD432D7F","latestVersionIndicator":"Yes","beginDate":"2016-06-14","endDate":null,"createdBy":"PATELV","dateCreated":"2016-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3542E427-B256-8E24-E050-BB89AD432D7F","beginDate":"2016-06-14","endDate":null,"createdBy":"PATELV","dateCreated":"2016-06-14","modifiedBy":"ONEDATA","dateModified":"2016-06-14","deletedIndicator":"No"},{"value":"Lack of confirmation of payment for treatment","valueDescription":"Lack of confirmation of payment for treatment","ValueMeaning":{"publicId":"5578403","version":"1","preferredName":"Lack of confirmation of payment for treatment","longName":"5578403","preferredDefinition":"Lack of confirmation of payment for treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"418462FF-DB79-589A-E053-F662850AA273","latestVersionIndicator":"Yes","beginDate":"2016-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-11-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"418462FF-DB92-589A-E053-F662850AA273","beginDate":"2016-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-11-17","modifiedBy":"ONEDATA","dateModified":"2016-11-17","deletedIndicator":"No"},{"value":"p53 deleted or mutant","valueDescription":"TP53 Gene Deletion Or Mutant","ValueMeaning":{"publicId":"5782164","version":"1","preferredName":"TP53 Gene Deletion Or Mutant","longName":"5782164","preferredDefinition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.: Elimination, especially by blotting out, cutting out, or erasing.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene","conceptCode":"C17359","definition":"This gene plays a critical role in cell cycle regulation and has tumor suppressor activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Deletion","conceptCode":"C61330","definition":"Elimination, especially by blotting out, cutting out, or erasing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutant","conceptCode":"C25360","definition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E11966F-A294-17A2-E053-F662850A1F89","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"PATELV","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4E11966F-A2AD-17A2-E053-F662850A1F89","beginDate":"2017-04-26","endDate":null,"createdBy":"PATELV","dateCreated":"2017-04-26","modifiedBy":"ONEDATA","dateModified":"2017-04-26","deletedIndicator":"No"},{"value":"Did not meet eligibility criteria","valueDescription":"Did not meet eligibility criteria","ValueMeaning":{"publicId":"2578433","version":"1","preferredName":"Did not meet eligibility criteria","longName":"2578433","preferredDefinition":"Did not meet eligibility criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-03-31","modifiedBy":"CAMPBELB","dateModified":"2006-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C2A59C-CF1E-277F-E053-F662850AD5DD","beginDate":"2018-03-06","endDate":null,"createdBy":"PATELV","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"Patient not interested in participating on a clinical trial","valueDescription":"Patient not interested in participating on a clinical trial","ValueMeaning":{"publicId":"6402198","version":"1","preferredName":"Patient not interested in participating on a clinical trial","longName":"6402198","preferredDefinition":"Patient not interested in participating on a clinical trial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A206D9-A5A3-4484-E053-F662850A97CB","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"PATELV","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73A206D9-A5BC-4484-E053-F662850A97CB","beginDate":"2018-08-17","endDate":null,"createdBy":"PATELV","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","deletedIndicator":"No"},{"value":"Does not speak English","valueDescription":"Does not speak English","ValueMeaning":{"publicId":"6402199","version":"1","preferredName":"Does not speak English","longName":"6402199","preferredDefinition":"Does not speak English","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A206D9-A5C6-4484-E053-F662850A97CB","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"PATELV","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73A206D9-A5DF-4484-E053-F662850A97CB","beginDate":"2018-08-17","endDate":null,"createdBy":"PATELV","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","deletedIndicator":"No"},{"value":"Does not have a PCP nor will obtain one","valueDescription":"Does not have a PCP nor will obtain one","ValueMeaning":{"publicId":"6402200","version":"1","preferredName":"Does not have a PCP nor will obtain one","longName":"6402200","preferredDefinition":"Does not have a PCP nor will obtain one","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73A206D9-A5E9-4484-E053-F662850A97CB","latestVersionIndicator":"Yes","beginDate":"2018-08-17","endDate":null,"createdBy":"PATELV","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"73A206D9-A602-4484-E053-F662850A97CB","beginDate":"2018-08-17","endDate":null,"createdBy":"PATELV","dateCreated":"2018-08-17","modifiedBy":"ONEDATA","dateModified":"2018-08-17","deletedIndicator":"No"},{"value":"PET/CT Positive","valueDescription":"Positron Emission Tomography and Computed Tomography Scan Positive","ValueMeaning":{"publicId":"7069539","version":"1","preferredName":"Positron Emission Tomography and Computed Tomography Scan Positive","longName":"7069539","preferredDefinition":"An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.: Involving advantage or good.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography and Computed Tomography Scan","conceptCode":"C103512","definition":"An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C04587-2452-1825-E053-F662850AC77E","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"98C04587-246B-1825-E053-F662850AC77E","beginDate":"2019-12-02","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","deletedIndicator":"No"},{"value":"PET/CT Indeterminate","valueDescription":"Positron Emission Tomography and Computed Tomography Scan Indeterminate","ValueMeaning":{"publicId":"7069540","version":"1","preferredName":"Positron Emission Tomography and Computed Tomography Scan Indeterminate","longName":"7069540","preferredDefinition":"An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.: Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography and Computed Tomography Scan","conceptCode":"C103512","definition":"An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C04587-2478-1825-E053-F662850AC77E","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"98C04587-2491-1825-E053-F662850AC77E","beginDate":"2019-12-02","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","deletedIndicator":"No"},{"value":"IDH Mutant","valueDescription":"IDH Gene Family Mutant","ValueMeaning":{"publicId":"7074695","version":"1","preferredName":"IDH Gene Family Mutant","longName":"7074695","preferredDefinition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.: An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH Gene Family","conceptCode":"C129260","definition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutant","conceptCode":"C25360","definition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"994C22F7-03D0-3D5E-E053-F662850A153E","latestVersionIndicator":"Yes","beginDate":"2019-12-09","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-09","modifiedBy":"ONEDATA","dateModified":"2019-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"994C22F7-03E9-3D5E-E053-F662850A153E","beginDate":"2019-12-09","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-09","modifiedBy":"ONEDATA","dateModified":"2019-12-09","deletedIndicator":"No"},{"value":"IDH Indeterminate","valueDescription":"IDH Gene Family Indeterminate","ValueMeaning":{"publicId":"7074694","version":"1","preferredName":"IDH Gene Family Indeterminate","longName":"7074694","preferredDefinition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.: Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH Gene Family","conceptCode":"C129260","definition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"994C22F7-03AA-3D5E-E053-F662850A153E","latestVersionIndicator":"Yes","beginDate":"2019-12-09","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-09","modifiedBy":"ONEDATA","dateModified":"2019-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"994C22F7-03C3-3D5E-E053-F662850A153E","beginDate":"2019-12-09","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-09","modifiedBy":"ONEDATA","dateModified":"2019-12-09","deletedIndicator":"No"},{"value":"Distant metastasis found on central PET/CT review","valueDescription":"Distant metastasis found on central PET/CT review","ValueMeaning":{"publicId":"7090197","version":"1","preferredName":"Distant metastasis found on central PET/CT review","longName":"7090197","preferredDefinition":"Distant metastasis found on central PET/CT review","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9973EDC1-24A4-777F-E053-F662850A2548","latestVersionIndicator":"Yes","beginDate":"2019-12-11","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9973EDC1-24BD-777F-E053-F662850A2548","beginDate":"2019-12-11","endDate":null,"createdBy":"PATELV","dateCreated":"2019-12-11","modifiedBy":"ONEDATA","dateModified":"2019-12-11","deletedIndicator":"No"},{"value":"Central review failure","valueDescription":"Central review failure","ValueMeaning":{"publicId":"7691370","version":"1","preferredName":"Central review failure","longName":"7691370","preferredDefinition":"Central review failure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4E6FF48-44D1-703C-E053-4EBD850A7AEF","latestVersionIndicator":"Yes","beginDate":"2021-06-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-06-16","modifiedBy":"ONEDATA","dateModified":"2021-06-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C4E6FF48-44EA-703C-E053-4EBD850A7AEF","beginDate":"2021-06-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2021-06-16","modifiedBy":"ONEDATA","dateModified":"2021-06-16","deletedIndicator":"No"},{"value":"Bulky residual disease","valueDescription":"Bulky residual disease","ValueMeaning":{"publicId":"8155662","version":"1","preferredName":"Bulky residual disease","longName":"8155662","preferredDefinition":"Bulky residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC259634-9CF5-49F6-E053-4EBD850A265A","latestVersionIndicator":"Yes","beginDate":"2022-04-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2022-04-08","modifiedBy":"ONEDATA","dateModified":"2022-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC259634-9D0E-49F6-E053-4EBD850A265A","beginDate":"2022-04-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2022-04-08","modifiedBy":"ONEDATA","dateModified":"2022-04-08","deletedIndicator":"No"},{"value":"Failure to collect plasma EBV DNA sample","valueDescription":null,"ValueMeaning":{"publicId":"13253756","version":"1","preferredName":"Failed Plasma Epstein-Barr Virus DNA Collection","longName":"13253756v1.00","preferredDefinition":"Having undergone failure; did not accomplish the intended purpose._Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation._The viral DNA that originates from Epstein-Barr virus._The act of gathering things together; having been brought together in one place.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failed","conceptCode":"C44281","definition":"Having undergone failure; did not accomplish the intended purpose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Plasma","conceptCode":"C13356","definition":"Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Epstein-Barr Virus DNA","conceptCode":"C129661","definition":"The viral DNA that originates from Epstein-Barr virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7E54BB7-FF3A-2EEC-E053-731AD00AEC97","latestVersionIndicator":"Yes","beginDate":"2023-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2023-03-27","modifiedBy":"TSESU","dateModified":"2023-03-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7E54BB7-FF3B-2EEC-E053-731AD00AEC97","beginDate":"2023-03-27","endDate":null,"createdBy":"TSESU","dateCreated":"2023-03-27","modifiedBy":"TSESU","dateModified":"2023-03-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-2E61-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"TSESU","dateModified":"2023-03-27","changeDescription":"Corrected typographical/spelling error in VD Name only - no other change.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"}]}],"AlternateNames":[{"name":"PROT_THR_PRCD_DISCONT_ADM_RSN","type":"Context Short Name","context":"CTEP"},{"name":"PR_TH_PRO_DIS_ADM_RSN","type":"Context Short Name","context":"CTEP"},{"name":"3219602v1.0:3219603v1.0","type":"USED_BY","context":"NRG"},{"name":"PT_NT_GNG_ON_STDY_RSN","type":"Context Short Name","context":"NRG"}],"ReferenceDocuments":[{"name":"If no, specify the reason the","type":"Preferred Question Text","description":"If no, specify the reason the patient cannot continue to Step 2","url":null,"context":"CTEP"},{"name":"If no, specify the reason the","type":"Alternate Question Text","description":"If no, specify the reason the patient cannot continue to Step 3","url":null,"context":"CTEP"},{"name":"NRG CRF_Text 1","type":"Alternate Question Text","description":"If no, specify the reason the patient is not going on study","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A018F73A-3011-0240-E040-BB89AD43705F","latestVersionIndicator":"Yes","beginDate":"2011-04-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-04","modifiedBy":"TIFFANIS","dateModified":"2018-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}